Fiduciary Trust’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.49M Buy
76,405
+3,512
+5% +$271K 0.06% 157
2025
Q4
$5.78M Sell
72,893
-1,792
-2% -$141K 0.07% 149
2025
Q3
$5.63M Sell
74,685
-3,479
-4% -$238K 0.06% 157
2025
Q2
$5.39M Sell
78,164
-1,502
-2% -$98.5K 0.07% 160
2025
Q1
$5.4M Sell
79,666
-9,468
-11% -$567K 0.07% 157
2024
Q4
$4M Sell
89,134
-19,017
-18% -$1.07M 0.05% 185
2024
Q3
$6.8M Buy
108,151
+375
+0.3% +$21.9K 0.1% 143
2024
Q2
$6.37M Sell
107,776
-71,765
-40% -$4.49M 0.1% 138
2024
Q1
$14.3M Sell
179,541
-3,322
-2% -$254K 0.22% 72
2023
Q4
$14.4M Sell
182,863
-13,099
-7% -$932K 0.24% 71
2023
Q3
$13.7M Sell
195,962
-5,687
-3% -$403K 0.25% 70
2023
Q2
$13.9M Sell
201,649
-11,561
-5% -$823K 0.25% 72
2023
Q1
$15.8M Sell
213,210
-3,976
-2% -$333K 0.29% 64
2022
Q4
$20.2M Buy
217,186
+1,175
+0.5% +$113K 0.39% 54
2022
Q3
$20.6M Buy
216,011
+3,045
+1% +$301K 0.45% 48
2022
Q2
$19.7M Sell
212,966
-910
-0.4% -$88.8K 0.42% 50
2022
Q1
$21.6M Sell
213,876
-1,133
-0.5% -$119K 0.39% 54
2021
Q4
$22.2M Sell
215,009
-1,282
-0.6% -$118K 0.36% 52
2021
Q3
$18.4M Sell
216,291
-2,241
-1% -$188K 0.33% 59
2021
Q2
$18.2M Sell
218,532
-11,526
-5% -$944K 0.35% 59
2021
Q1
$17.3M Sell
230,058
-8,606
-4% -$627K 0.35% 59
2020
Q4
$16.3M Sell
238,664
-1,886
-0.8% -$123K 0.34% 59
2020
Q3
$14M Buy
240,550
+13,025
+6% +$810K 0.33% 61
2020
Q2
$14.8M Sell
227,525
-13,802
-6% -$869K 0.37% 60
2020
Q1
$14.3M Buy
241,327
+25,799
+12% +$1.72M 0.42% 58
2019
Q4
$16M Sell
215,528
-8,995
-4% -$632K 0.37% 59
2019
Q3
$14.2M Sell
224,523
-4,337
-2% -$257K 0.36% 65
2019
Q2
$12.5M Sell
228,860
-20,378
-8% -$1.1M 0.33% 71
2019
Q1
$13.4M Sell
249,238
-10,791
-4% -$666K 0.36% 65
2018
Q4
$17M Buy
260,029
+3,044
+1% +$227K 0.52% 51
2018
Q3
$20.2M Sell
256,985
-11,699
-4% -$836K 0.57% 45
2018
Q2
$17.3M Sell
268,684
-74,401
-22% -$4.9M 0.52% 54
2018
Q1
$21.3M Sell
343,085
-9,445
-3% -$678K 0.66% 42
2017
Q4
$25.6M Sell
352,530
-10,513
-3% -$764K 0.76% 37
2017
Q3
$29.5M Sell
363,043
-8,280
-2% -$655K 0.91% 28
2017
Q2
$29.9M Buy
371,323
+5,316
+1% +$420K 0.92% 26
2017
Q1
$28.7M Buy
366,007
+4,265
+1% +$340K 0.88% 25
2016
Q4
$28.5M Buy
361,742
+36,620
+11% +$2.96M 0.92% 23
2016
Q3
$28.9M Sell
325,122
-5,178
-2% -$489K 0.99% 23
2016
Q2
$31.6M Sell
330,300
-9,134
-3% -$910K 1.11% 19
2016
Q1
$35.2M Buy
339,434
+25,214
+8% +$2.45M 1.24% 18
2015
Q4
$30.7M Sell
314,220
-4,982
-2% -$488K 1.3% 19
2015
Q3
$30.8M Sell
319,202
-20,395
-6% -$2.14M 1.39% 20
2015
Q2
$35.6M Sell
339,597
-6,663
-2% -$681K 1.48% 18
2015
Q1
$35.7M Sell
346,260
-5,351
-2% -$541K 1.48% 14
2014
Q4
$33.9M Buy
351,611
+4,346
+1% +$383K 1.42% 16
2014
Q3
$27.6M Buy
347,265
+616
+0.2% +$48.6K 1.22% 20
2014
Q2
$26.1M Buy
346,649
+5,889
+2% +$445K 1.12% 24
2014
Q1
$25.5M Sell
340,760
-2,482
-0.7% -$175K 1.13% 24
2013
Q4
$24.6M Sell
343,242
-2,828
-0.8% -$182K 1.09% 23
2013
Q3
$19.6M Buy
346,070
+2,337
+0.7% +$139K 0.9% 32
2013
Q2
$19.7M Buy
+343,733
New +$19.9M 0.91% 30

Other funds holding CVS

Fiduciary Trust's CVS Position: Q1 2026 in Review

Fiduciary Trust increased its CVS Health (CVS) stake by 4.8% in Q1 2026, buying an estimated $271K and bringing the position to 76,405 shares worth $5.49M. The position accounts for 0.06% of the portfolio, ranked #157.

Fiduciary Trust first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.7M in Q1 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Fiduciary Trust held 76,405 shares of CVS Health worth $5.49M as of Q1 2026.
  • Fiduciary Trust bought 3,512 CVS Health shares in Q1 2026, an estimated $271K.
  • CVS Health made up 0.06% of Fiduciary Trust's portfolio in Q1 2026, its #157 holding.
  • Fiduciary Trust first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's CVS Health position peaked at $35.7M in Q1 2015.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.